- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.01. | Catheter Precision, Inc.: Catheter Precision Receives First Purchase Order for LockeT in Germany | 728 | GlobeNewswire (Europe) | FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 20.01. | Catheter Precision, Inc.: Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia | 4 | GlobeNewswire (USA) | ||
| 25.11.25 | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 954 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 14.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Catheter Precision reports Q3 results | 1 | Seeking Alpha | ||
| 13.11.25 | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations | 696 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace... ► Artikel lesen | |
| 13.11.25 | Catheter Precision, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.10.25 | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | 222 | GlobeNewswire (Europe) | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
| 15.10.25 | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.25 | Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO | 185 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 10.09.25 | Catheter Precision, Inc.: Catheter Precision Announces Tender Win and First Purchase Order in Croatia | 1.134 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 04.09.25 | Catheter Precision, Inc.: Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 28.08.25 | Catheter Precision, Inc.: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues | 1 | GlobeNewswire (USA) | ||
| 21.08.25 | Catheter Precision, Inc.: Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study | 2 | GlobeNewswire (USA) | ||
| 18.08.25 | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.08.25 | Catheter Precision's LockeT Wound Closure Device Approved In UK; Shares Soar Over 65% | 1 | RTTNews | ||
| 15.08.25 | Catheter Precision executes 1-for-19 reverse stock split | 2 | Seeking Alpha | ||
| 15.08.25 | Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split | 511 | GlobeNewswire (Europe) | FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for... ► Artikel lesen | |
| 15.08.25 | XFRA 4RM: AUSSETZUNG/SUSPENSION | 496 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCATHETER PR. NEW... ► Artikel lesen |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,290 | -0,76 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
26.01.2026 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,450 | +0,48 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 37,40 Euro auf "Underweight" belassen. Analyst David Adlington nahm am Donnerstagabend in seinem... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,520 | -0,13 % | Gerüchte & Nervosität bei Eckert&Ziegler: Was steckt dahinter? | ||
| BICO GROUP | 1,662 | -2,86 % | BICO Group AB: BICO company Biosero launches GoSimple, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) | Biosero, part of the BICO Group and a leader in lab automation, will launch the GoSimple workcell at SLAS 2026 (February 7-11, Boston, US). GoSimple is a standardized, automation-ready workcell designed... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,100 | -0,99 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| RESMED | 214,90 | -0,42 % | Resmed's Q2 Earnings on Deck: What's in Store for the Stock? | ||
| CARDINAL HEALTH | 175,50 | -0,34 % | Cardinal Health stock price target raised to $233 from $225 at TD Cowen | ||
| ATOSSA THERAPEUTICS | 0,524 | +1,75 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| ZIMMER BIOMET | 72,32 | +0,81 % | TD Cowen assumes coverage on Zimmer Biomet stock with Buy rating | ||
| UNIDOC HEALTH | 0,100 | +5,94 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development | BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 22.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.01.2026ISIN NameCA74290F1009 PROBE... ► Artikel lesen | |
| CYTOSORBENTS | 0,592 | +4,59 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| VERU | 2,615 | -2,43 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| CLARIANE | 3,966 | -0,20 % | Pflege braucht Vielfalt: Jetzt für den Korian Stiftungsaward 2026 bewerben | München (ots) - Die Korian Stiftung für Pflege und würdevolles Altern schreibt zum sechsten Mal ihren Award für Vielfalt und Respekt in der Pflege aus. Ausgezeichnet werden Einrichtungen, Pflegedienste... ► Artikel lesen |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,140 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.